Cargando…
UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib
Ubiquitin-like 3 (UBL3) acts as a post-translational modification (PTM) factor and regulates protein sorting into small extracellular vesicles (sEVs). sEVs have been reported as vectors for the pathology propagation of neurodegenerative diseases, such as α-synucleinopathies. Alpha-synuclein (α-syn)...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295865/ https://www.ncbi.nlm.nih.gov/pubmed/37371780 http://dx.doi.org/10.3390/biomedicines11061685 |
_version_ | 1785063522429829120 |
---|---|
author | Chen, Bin Hasan, Md. Mahmudul Zhang, Hengsen Zhai, Qing Waliullah, A. S. M. Ping, Yashuang Zhang, Chi Oyama, Soho Mimi, Mst. Afsana Tomochika, Yuna Nagashima, Yu Nakamura, Tomohiko Kahyo, Tomoaki Ogawa, Kenji Kaneda, Daita Yoshida, Minoru Setou, Mitsutoshi |
author_facet | Chen, Bin Hasan, Md. Mahmudul Zhang, Hengsen Zhai, Qing Waliullah, A. S. M. Ping, Yashuang Zhang, Chi Oyama, Soho Mimi, Mst. Afsana Tomochika, Yuna Nagashima, Yu Nakamura, Tomohiko Kahyo, Tomoaki Ogawa, Kenji Kaneda, Daita Yoshida, Minoru Setou, Mitsutoshi |
author_sort | Chen, Bin |
collection | PubMed |
description | Ubiquitin-like 3 (UBL3) acts as a post-translational modification (PTM) factor and regulates protein sorting into small extracellular vesicles (sEVs). sEVs have been reported as vectors for the pathology propagation of neurodegenerative diseases, such as α-synucleinopathies. Alpha-synuclein (α-syn) has been widely studied for its involvement in α-synucleinopathies. However, it is still unknown whether UBL3 interacts with α-syn, and is influenced by drugs or compounds. In this study, we investigated the interaction between UBL3 and α-syn, and any ensuing possible functional and pathological implications. We found that UBL3 can interact with α-syn by the Gaussia princeps based split luciferase complementation assay in cells and immunoprecipitation, while cysteine residues at its C-terminal, which are considered important as PTM factors for UBL3, were not essential for the interaction. The interaction was upregulated by 1-methyl-4-phenylpyridinium exposure. In drug screen results, the interaction was significantly downregulated by the treatment of osimertinib. These results suggest that UBL3 interacts with α-syn in cells and is significantly downregulated by epidermal growth factor receptor (EGFR) pathway inhibitor osimertinib. Therefore, the UBL3 pathway may be a new therapeutic target for α-synucleinopathies in the future. |
format | Online Article Text |
id | pubmed-10295865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102958652023-06-28 UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib Chen, Bin Hasan, Md. Mahmudul Zhang, Hengsen Zhai, Qing Waliullah, A. S. M. Ping, Yashuang Zhang, Chi Oyama, Soho Mimi, Mst. Afsana Tomochika, Yuna Nagashima, Yu Nakamura, Tomohiko Kahyo, Tomoaki Ogawa, Kenji Kaneda, Daita Yoshida, Minoru Setou, Mitsutoshi Biomedicines Article Ubiquitin-like 3 (UBL3) acts as a post-translational modification (PTM) factor and regulates protein sorting into small extracellular vesicles (sEVs). sEVs have been reported as vectors for the pathology propagation of neurodegenerative diseases, such as α-synucleinopathies. Alpha-synuclein (α-syn) has been widely studied for its involvement in α-synucleinopathies. However, it is still unknown whether UBL3 interacts with α-syn, and is influenced by drugs or compounds. In this study, we investigated the interaction between UBL3 and α-syn, and any ensuing possible functional and pathological implications. We found that UBL3 can interact with α-syn by the Gaussia princeps based split luciferase complementation assay in cells and immunoprecipitation, while cysteine residues at its C-terminal, which are considered important as PTM factors for UBL3, were not essential for the interaction. The interaction was upregulated by 1-methyl-4-phenylpyridinium exposure. In drug screen results, the interaction was significantly downregulated by the treatment of osimertinib. These results suggest that UBL3 interacts with α-syn in cells and is significantly downregulated by epidermal growth factor receptor (EGFR) pathway inhibitor osimertinib. Therefore, the UBL3 pathway may be a new therapeutic target for α-synucleinopathies in the future. MDPI 2023-06-10 /pmc/articles/PMC10295865/ /pubmed/37371780 http://dx.doi.org/10.3390/biomedicines11061685 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Bin Hasan, Md. Mahmudul Zhang, Hengsen Zhai, Qing Waliullah, A. S. M. Ping, Yashuang Zhang, Chi Oyama, Soho Mimi, Mst. Afsana Tomochika, Yuna Nagashima, Yu Nakamura, Tomohiko Kahyo, Tomoaki Ogawa, Kenji Kaneda, Daita Yoshida, Minoru Setou, Mitsutoshi UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title | UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title_full | UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title_fullStr | UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title_full_unstemmed | UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title_short | UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib |
title_sort | ubl3 interacts with alpha-synuclein in cells and the interaction is downregulated by the egfr pathway inhibitor osimertinib |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295865/ https://www.ncbi.nlm.nih.gov/pubmed/37371780 http://dx.doi.org/10.3390/biomedicines11061685 |
work_keys_str_mv | AT chenbin ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT hasanmdmahmudul ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT zhanghengsen ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT zhaiqing ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT waliullahasm ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT pingyashuang ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT zhangchi ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT oyamasoho ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT mimimstafsana ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT tomochikayuna ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT nagashimayu ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT nakamuratomohiko ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT kahyotomoaki ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT ogawakenji ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT kanedadaita ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT yoshidaminoru ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib AT setoumitsutoshi ubl3interactswithalphasynucleinincellsandtheinteractionisdownregulatedbytheegfrpathwayinhibitorosimertinib |